| Literature DB >> 22238648 |
Abstract
BACKGROUND: Zoonotic diseases account for over 60% of all communicable diseases causing illness in humans and 75% of recently emerging infectious diseases. As limited resources are available for the control and prevention of zoonotic diseases, it is necessary to prioritize diseases in order to direct resources into those with the greatest needs. The selection of criteria for prioritization has traditionally been on the basis of expert opinion; however, details of the methods used to identify criteria from expert opinion often are not published and a full range of criteria may not be captured by expert opinion. METHODOLOGY/PRINCIPALEntities:
Mesh:
Year: 2012 PMID: 22238648 PMCID: PMC3253104 DOI: 10.1371/journal.pone.0029752
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Summary of methods used in criteria identification in prioritization exercises conducted between 1997 and 2004.
| Country or region (Study year) | Diseases or pathogens of interest | Number of criteria identified | Methods used in criteria identification | Reference(s) |
| United Kingdom (1997) | 33 communicable diseases and 8 generic disease groups | 6 | Not published, expert opinion (n = ?) |
|
| “ | ||||
| United Kingdom (1999) | 58 pathogens or communicable diseases and 11 generic disease groups | 5 | Not published, expert opinion (n = ?) |
|
| “ | ||||
| Canada (2000) | 43 communicable diseases | 10 | Not published, expert opinion and consensus of the subcommittee (n = ?). |
|
| “ | ||||
| France (2000–2001) | 37 non-food borne zoonoses | 6 | Not published, expert opinion (n = 10) |
|
| “ | ||||
| WHO Eastern Europe (7 countries) (2002) | 53 communicable diseases | 8 | Not published, expert opinion (n = 24) |
|
| “ | ||||
| Germany (2004) | 85 pathogens | 12 | Not published, expert opinion (n = 11) |
|
| “ |
Summary of methods used in criteria identification in prioritization exercises conducted between 2005 and 2011.
| Country or region (Study year) | Diseases or pathogens of interest | Number of criteria identified | Methods used in criteria identification | Reference(s) |
| Canada (2005) | 48 communicable diseases | 10 | Not published, expert opinion and consensus of the subcommittee (n = ?) |
|
| Continuation of the work conducted in 2000 | ||||
| France (2005–2008) | 37 non-food borne zoonoses | 6 | Not published, expert opinion (n = 16) |
|
| Continuation of the work from the initial meeting in 2000–2001 | ||||
| Belgium (2008) | 51 food- and water-borne zoonotic pathogens | 5 | Not published, expert opinion (n = ?) |
|
| “ | ||||
| The Netherlands (2010) | 86 emerging zoonotic pathogens | 7 | Not published, expert opinion (n = ?). |
|
| “ | ||||
| “ | ||||
| Germany (2011) | 127 pathogens | 10 | Not published, expert opinion (n = 11+72) |
|
| “ |
Demographic characteristics of focus group participants.
| Focus Group Number | Public or Professional | Number of individuals in the group | Males | Females | Average age (range) | Highest level of Education | Number of criteria identified as a group |
| 1 | Public | 9 | 6 | 3 | 38.3 (21 to 56) | High school (4), college diploma (2), Bachelors degree (2), Masters degree (1); all in unrelated fields | 24 |
| 2 | Public | 9 | 5 | 4 | 41.4 (20 to 70) | High school (2), college diploma (3), Bachelors degree (4); all in unrelated fields | 27 |
| 3 | Public | 10 | 4 | 6 | 40.2 (21 to 67) | High school (5), college diploma (1), Bachelors degree (3), Masters degree (1); all in unrelated fields | 24 |
| 4 | Professional (animal health experts and decision-makers) | 10 | 8 | 2 | 47.7 (39 to 59) | PhD (7) and/or DVM/DVSc (7) | 33 |
| 5 | Professional (human health experts and decision-makers) | 8 | 5 | 3 | 47.1 (33 to 52) | Diploma (1), Bachelors degree (1), Masters (1), PhD (4) and/or MD (1) | 25 |
| 6 | Professional (mix of animal and human health experts and decision-makers) | 8 (four animal health and four human health professionals) | 3 | 5 | 42.7 (30 to 58) | Masters (1), PhD (4) and/or MD (1) and/or DVM/DVSc (3) | 31 |
|
|
|
|
|
|
|
|
|
*Excluded fields include medical and veterinary sciences, epidemiology and public health sciences, infectious diseases research including laboratory work on infectious diseases, nurses, and dentists.
Fifty-nine unique criteria identified collectively by six focus groups for prioritizing zoonotic diseases in Canada (Part 1).
| Criteria | Theme | Human, animal, pathogen or disease | Public Groups | Professional Groups | Mean Score | Frequency | |||||
| 1 | 2 | 3 | AH | HH | A/H | ||||||
| 1 | Mortality characteristics in humans | Burden of illness | Human | 2 | 1 | 1 | 1 | 8.6 | 4 | ||
| 2 | Severity of illness in humans | Burden of illness | Human | 1 | 1 | 1 | 1 | 1 | 1 | 7.6 | 6 |
| 3 | Duration of illness in humans | Burden of illness | Human | 2 | 6.0 | 1 | |||||
| 4 | Co-infection in humans | Burden of illness | Human | 1 | 5.1 | 1 | |||||
| 5 | Reproductive consequences in humans | Burden of illness | Human | 1 | 4.4 | 1 | |||||
| 6 | Severity of illness in animals | Burden of illness | Animal | 1 | 1 | 1 | 1 | 6.8 | 4 | ||
| 7 | Combination of disease risk and probability of infection | Disease epidemiology | Human | 1 | 8.6 | 1 | |||||
| 8 | Potential for animal-to-human transmission | Disease epidemiology | Human | 1 | 1 | 8.2 | 2 | ||||
| 9 | Speed of transmission between humans | Disease epidemiology | Human | 1 | 1 | 1 | 8.0 | 3 | |||
| 10 | Incidence or prevalence in humans | Disease epidemiology | Human | 1 | 1 | 7.5 | 2 | ||||
| 11 | Potential for human-to-human transmission | Disease epidemiology | Human | 1 | 1 | 1 | 1 | 7.9 | 4 | ||
| 12 | Risk of transmission in humans | Disease epidemiology | Human | 1 | 7.6 | 1 | |||||
| 13 | Speed of disease spread in individuals (incubation period) | Disease epidemiology | Human | 1 | 2 | 2 | 7.0 | 3 | |||
| 14 | High-risk groups in humans | Disease epidemiology | Human | 1 | 1 | 1 | 1 | 1 | 1 | 6.5 | 6 |
| 15 | Immunogenicity in humans | Disease epidemiology | Human | 1 | 1 | 1 | 5.0 | 3 | |||
| 16 | Risk of endemicity in humans | Disease epidemiology | Human | 1 | 5.0 | 1 | |||||
| 17 | Impact of climate change on vectors and animal hosts | Disease epidemiology | Animal | 2 | 7.0 | 1 | |||||
| 18 | Incidence or prevalence in animals | Disease epidemiology | Animal | 1 | 1 | 5.5 | 2 | ||||
| 19 | Specific types of animals involved | Disease epidemiology | Animal | 1 | 1 | 6.3 | 2 | ||||
| 20 | Size of the reservoir host (animal and environment) | Disease epidemiology | Animal | 1 | 2 | 2 | 6.2 | 3 | |||
| 21 | Potential for animal-to-animal transmission | Disease epidemiology | Animal | 1 | 2 | 6.1 | 2 | ||||
| 22 | Potential for human-to-animal transmission | Disease epidemiology | Animal | 1 | 1 | 1 | 5.5 | 3 | |||
| 23 | Risk of endemicity in animals | Disease epidemiology | Animal | 1 | 5.1 | 1 | |||||
| 24 | High-risk groups in animals | Disease epidemiology | Animal | 1 | 4.5 | 1 | |||||
AH = animal health professional group, HH = human health professional group and A/H = mixed animal and human health professional group.
Mean score on a scale of 1 being the least important to 9 being the most important.
The number of focus groups that identified the unique criterion; 1 indicates only one focus group listed the criterion while 6 indicates all focus groups listed the criterion.
The number of times the unique criterion was identified by each focus group; 2 or more indicates the criterion was listed more than once but expressed in different terms by the focus group.
Fifty-nine unique criteria identified collectively by six focus groups for prioritizing zoonotic diseases in Canada (Part 2).
| Criteria | Theme | Human, animal, pathogen or disease | Public Groups | Professional Groups | Mean Score | Frequency | |||||
| 1 | 2 | 3 | AH | HH | A/H | ||||||
| 25 | Mode of transmission | Disease epidemiology | Pathogen/disease | 1 | 1 | 1 | 1 | 1 | 1 | 7.2 | 6 |
| 26 | Pathogenicity and virulence of the pathogen | Disease epidemiology | Pathogen/disease | 1 | 2 | 6.7 | 2 | ||||
| 27 | Range of pathogens | Disease epidemiology | Pathogen/disease | 1 | 6.8 | 1 | |||||
| 28 | Disease trend | Disease epidemiology | Pathogen/disease | 1 | 1 | 1 | 1 | 6.2 | 4 | ||
| 29 | Ability of the pathogen to mutate and adapt to change | Disease epidemiology | Pathogen/disease | 1 | 1 | 2 | 3 | 5.8 | 4 | ||
| 30 | Endemicity of the disease due to climate | Disease epidemiology | Pathogen/disease | 1 | 1 | 4.1 | 2 | ||||
| 31 | Seasonality of the disease | Disease epidemiology | Pathogen/disease | 1 | 1 | 1 | 3.5 | 3 | |||
| 32 | Treatment and prevention in humans | Control measures | Human | 2 | 4 | 2 | 2 | 2 | 1 | 7.2 | 6 |
| 33 | Potential to eradicate the disease in humans | Control measures | Human | 1 | 1 | 1 | 6.5 | 3 | |||
| 34 | Visual cues to avoid the disease in humans | Control measures | Human | 1 | 1 | 1 | 6.0 | 3 | |||
| 35 | Surveillance in humans | Control measures | Human | 1 | 5.9 | 1 | |||||
| 36 | Human cause versus a natural cause | Control measures | Human | 1 | 5.9 | 1 | |||||
| 37 | Disease in human beyond control measures | Control measures | Human | 1 | 1 | 5.8 | 2 | ||||
| 38 | Vaccine/antiviral manufacturing time | Control measures | Human | 1 | 5.8 | 1 | |||||
| 39 | Potential to eradicate the disease in animals | Control measures | Animal | 1 | 6.5 | 1 | |||||
| 40 | Treatment and prevention in animals | Control measures | Animal | 1 | 2 | 1 | 6.2 | 3 | |||
| 41 | Surveillance in animals | Control measures | Animal | 1 | 5.6 | 1 | |||||
| 42 | Risk of bioterrorism | Socioeconomic impact | Human | 1 | 1 | 6.7 | 2 | ||||
| 43 | Political impact of the disease in humans | Socioeconomic impact | Human | 1 | 6.4 | 1 | |||||
| 44 | Risk to the food and water supply | Socioeconomic impact | Human | 1 | 2 | 6.4 | 2 | ||||
| 45 | Socioeconomic burden of the disease in humans | Socioeconomic impact | Human | 1 | 2 | 2 | 2 | 1 | 1 | 5.6 | 6 |
| 46 | Psychological impact in humans | Socioeconomic impact | Human | 1 | 5.4 | 1 | |||||
| 47 | Socioeconomic burden of the disease at the individual/farm level | Socioeconomic impact | Animal | 1 | 1 | 5.8 | 2 | ||||
| 48 | Socioeconomic burden of the disease on the industry | Socioeconomic impact | Animal | 1 | 1 | 1 | 2 | 6.3 | 4 | ||
AH = animal health professional group, HH = human health professional group and A/H = mixed animal and human health professional group.
Mean score on a scale of 1 being the least important to 9 being the most important.
The number of focus groups that identified the unique criterion; 1 indicates only one focus group listed the criterion while 6 indicates all focus groups listed the criterion.
The number of times the unique criterion was identified by each focus group; 2 or more indicates the criterion was listed more than once but expressed in different terms by the focus group.
Fifty-nine unique criteria identified collectively by six focus groups for prioritizing zoonotic diseases in Canada (Part 3).
| Criteria | Theme | Human, animal, pathogen or disease | Public Groups | Professional Groups | Mean Score | Frequency | |||||
| 1 | 2 | 3 | AH | HH | A/H | ||||||
| 49 | Ease of diagnosis and lead-time in diagnosis in humans | Diagnosis | Human | 1 | 1 | 1 | 6.0 | 3 | |||
| 50 | Availability of diagnostic tests in humans | Diagnosis | Human | 1 | 6.3 | 1 | |||||
| 51 | Test characteristics in humans (accuracy, multiple tests) | Diagnosis | Human | 1 | 3.9 | 1 | |||||
| 52 | Availability of diagnostic tests in animals | Diagnosis | Animal | 1 | 6.0 | 1 | |||||
| 53 | Scientific knowledge of the disease | Disease knowledge | Pathogen/disease | 1 | 1 | 1 | 1 | 6.3 | 4 | ||
| 54 | Public disruption | Public awareness and concerns | Human | 1 | 7.7 | 1 | |||||
| 55 | Public awareness | Public awareness and concerns | Human | 1 | 7.5 | 1 | |||||
| 56 | Public perception | Public awareness and concerns | Human | 1 | 1 | 1 | 5.6 | 3 | |||
| 57 | Geographic distribution of the disease | International considerations | Pathogen/disease | 1 | 1 | 1 | 1 | 4.6 | 4 | ||
| 58 | Geographic source of the disease | International considerations | Pathogen/disease | 1 | 5.1 | 1 | |||||
| 59 | Disease occurring in jurisdiction of interest | Local considerations | Pathogen/disease | 1 | 7.0 | 1 | |||||
|
|
|
|
|
|
|
|
|
| |||
|
|
|
|
|
| |||||||
AH = animal health professional group, HH = human health professional group and A/H = mixed animal and human health professional group.
Mean score on a scale of 1 being the least important to 9 being the most important.
The number of focus groups that identified the unique criterion; 1 indicates only one focus group listed the criterion while 6 indicates all focus groups listed the criterion.
The number of times the unique criterion was identified by each focus group; 2 or more indicates the criterion was listed more than once but expressed in different terms by the focus group.
Top 10 criteria rank-ordered by mean score by the public and professional focus groups.
| Rank | Focus group | Criteria | Themes | Human, animal or pathogen/disease | Mean Score |
| 1 | Public | Mortality characteristics in humans | Burden of illness | Human | 8.6 |
| 2 | Public | Speed of transmission between humans | Disease epidemiology | Human | 8.0 |
| 3 | Public | Treatment and prevention in humans | Control measures | Human | 7.5 |
| 4 | Public | Severity of illness in animals | Burden of illness | Animal | 7.5 |
| 5 | Public | Public awareness | Public concerns | Human | 7.5 |
| 6 | Public | Scientific knowledge of the disease | Disease knowledge | Pathogen/disease | 7.5 |
| 7 | Public | Mode of transmission | Disease epidemiology | Pathogen | 7.4 |
| 8 | Public | Potential to eradicate the disease in humans | Control measures | Human | 7.3 |
| 9 | Public | Speed of disease spread in individuals (incubation period) | Disease epidemiology | Human | 7.0 |
| 10 | Public | Potential for human-to-human transmission | Disease epidemiology | Human | 6.9 |
| 1 | Professional | Mortality characteristics in humans | Burden of illness | Human | 8.7 |
| 2 | Professional | Combination of disease risk and probability of infection | Disease epidemiology | Human | 8.6 |
| 3 | Professional | Severity of illness in humans | Burden of illness | Human | 8.4 |
| 4 | Professional | Potential for human-to-human transmission | Disease epidemiology | Human | 8.2 |
| 5 | Professional | Potential for animal-to-human transmission | Disease epidemiology | Human | 8.2 |
| 6 | Professional | Public disruption | Public concerns | Human | 7.7 |
| 7 | Professional | Risk of transmission in humans | Epidemiology | Human | 7.6 |
| 8 | Professional | Incidence or prevalence in humans | Disease epidemiology | Human | 7.5 |
| 9 | Professional | Socioeconomic burden of the disease in humans | Socioeconomic impact | Human | 7.1 |
| = 10 | Professional | Impact of climate change on vectors and animal hosts | Disease epidemiology | Animal | 7.0 |
| = 10 | Professional | Mode of transmission | Disease epidemiology | Pathogen | 7.0 |
Shared criterion identified as one of top ten criteria by both the public and the professional groups.
Bottom 10 criteria rank-ordered by mean score by the public and professional focus groups.
| Rank | Focus group | Criteria | Themes | Human, animal or pathogen/disease | Mean Score |
| 35 | Public | Seasonality of the disease | Disease epidemiology | Disease | 3.6 |
| 34 | Public | Endemicity of the disease due to climate | Disease epidemiology | Disease | 4.1 |
| 33 | Public | Socioeconomic burden of the disease in humans | Socioeconomic impact | Human | 4.1 |
| 32 | Public | Reproductive consequences in humans | Burden of illness | Human | 4.4 |
| 31 | Public | Geographic distribution of the disease | International considerations | Pathogen/disease | 4.8 |
| 30 | Public | Disease in human beyond control measures | Control measures | Human | 4.8 |
| 29 | Public | Disease trend | Disease epidemiology | Disease | 5.0 |
| 28 | Public | Co-infection in humans | Burden of illness | Human | 5.1 |
| 27 | Public | Geographic source of the disease | International considerations | Pathogen/disease | 5.1 |
| 26 | Public | Immunogenicity in humans | Disease epidemiology | Human | 5.2 |
| 46 | Professional | Seasonality of the disease | Disease epidemiology | Disease | 3.3 |
| 45 | Professional | Test characteristics in humans (accuracy, multiple tests) | Diagnosis | Human | 3.9 |
| 44 | Professional | Geographic distribution of the disease | International considerations | Pathogen/disease | 4.0 |
| 43 | Professional | High-risk groups in animals | Disease epidemiology | Animal | 4.5 |
| 42 | Professional | Immunogenicity in humans | Disease epidemiology | Human | 4.6 |
| 41 | Professional | Ease of diagnosis and lead-time in diagnosis in humans | Diagnosis | Human | 4.9 |
| 40 | Professional | Risk of endemicity in humans | Disease epidemiology | Human | 5.0 |
| 39 | Professional | Scientific knowledge of the disease | Disease knowledge | Pathogen/disease | 5.1 |
| 38 | Professional | Potential to eradicate the disease in humans | Control measures | Human | 5.1 |
| 37 | Professional | Risk of endemicity in animals | Disease epidemiology | Animal | 5.1 |
Shared criterion identified as one of bottom ten criteria by both the public and the professional groups.
List of criteria most frequently identified by the public and professional focus groups.
| Focus group | Criteria | Themes | Human, animal or pathogen/disease | Frequency |
| Public | Severity of illness in humans | Burden of illness | Human | 3 |
| Public | Treatment and prevention in humans | Control measures | Human | 3 |
| Public | High-risk groups in humans | Disease epidemiology | Human | 3 |
| Public | Socioeconomic burden of the disease in humans | Socioeconomic impact | Human | 3 |
| Public | Mode of transmission | Disease epidemiology | Pathogen | 3 |
| Public | Mortality characteristics in humans | Burden of illness | Human | 3 |
| Public | Geographic distribution of the disease | International considerations | Pathogen/disease | 3 |
| Public | Speed of disease spread in individuals (incubation period) | Disease epidemiology | Human | 3 |
| Public | Speed of transmission between humans | Disease epidemiology | Human | 3 |
| Public | Visual cues to avoid the disease in humans | Control measures | Human | 3 |
| Professional | Severity of illness in humans | Burden of illness | Human | 3 |
| Professional | Treatment and prevention in humans | Control measures | Human | 3 |
| Professional | High-risk groups in humans | Disease epidemiology | Human | 3 |
| Professional | Socioeconomic burden of the disease in humans | Socioeconomic impact | Human | 3 |
| Professional | Mode of transmission | Disease epidemiology | Pathogen | 3 |
| Professional | Severity of illness in animals | Burden of illness | Animal | 3 |
| Professional | Disease trend | Disease epidemiology | Disease | 3 |
| Professional | Potential for human-to-human transmission | Disease epidemiology | Human | 3 |
| Professional | Socioeconomic burden of the disease on the industry | Socioeconomic impact | Animal | 3 |
| Professional | Public perception | Public concerns | Human | 3 |
| Professional | Potential for human-to-animal transmission | Disease epidemiology | Animal | 3 |
Shared criterion identified by all six focus groups.
*Unique criterion identified only by either the public or professional groups.
Criteria are not listed in any particular order. All listed criteria were identified by all three public or professional focus groups.